She returns to the plaintiff table and sits down, the chair creaking once more. Lucas taps a quick line into his laptop, and she glances over to read the text on screen: Opening statement complete, 4 minutes 22 seconds. She gives a faint, silent nod. Whitfield stands, his chair scraping against the floor. He fastens both of his blazer buttons, aligning them perfectly, plastic clicking as his fingers make contact with each dome. “Your Honor, defendant Meridian Pharmaceuticals categorically denies all allegations brought against us.” His tone is low, graveled, calibrated by decades of courtroom work — precise pauses separate each sentence, giving the jury ample time to absorb every word. “Meridian’s generic drug is the fruit of entirely independent internal research, filed under the full regulatory scope of the FDA’s 505(b)(2) new drug application pathway. The plaintiff’s accusation of ‘technical t
Última actualización : 2026-07-19 Leer más